Searchable abstracts of presentations at key conferences on calcified tissues

ba0003pp337 | Osteoporosis: treatment | ECTS2014

Monitoring of calcium intake and vitamin D saturation in Slovak postmenopausal women

Vanuga Peter , Tomkova Sona , Jackuliak Peter , Killinger Zdenko , Payer Juraj

According various guidelines the basic recommendation in prevention and treatment of postmenopausal osteoporosis (PMO) is adequate intake of calcium (1000– 1300 mg/day) and vitamin D (800–1000 IU/day).Aim: To determine the intake dose of calcium and also the vitamin D saturation in women treated for PMO.Patients and methods: 465 women with PMO, divided into two groups: patients with newly diagnosed osteoporosis (n</em...

ba0003pp342 | Osteoporosis: treatment | ECTS2014

Assessment treatment with denosumab in clinical practice

Torrea Maria , Carretero Lorena , Filgueira Jose Santiago

Introduction: Denosumab monoclonal antibody approved for Osteoporosis’s treatment in Europe union and U.S.A. Dose of 60 mg every 6 months reduces the risk of vertebral, non vertebral and hip fractures. What is more increases BMDMaterial and methods: Descriptive observational study with densitometric characterisques and risk factors of 64 patients in Osteoporosis unit of HGUG Marañón from November 2011 to December 2013. Analyzing occurrence...

ba0003pp354 | Osteoporosis: treatment | ECTS2014

Denosumab treatment in women with osteoporosis reduces hip cortical porosity

Zebaze Roger M , Libanati Cesar , McClung Michael R , Zanchetta Jose R , Kendler David L , Hoiseth Arne , Wang Andrea , Ghasem-Zadeh Ali , Seeman Ego

Bone strength is influenced by cortical thickness, area, mass and porosity, all of which contribute to nonvertebral fracture risk. Cortical porosity is one parameter of structural decay associated with bone fragility. This is caused by unbalanced and accelerated remodelling of Haversian units which enlarge, coalesce and fragment the cortex. Antiresorptive therapies will limit progression of cortical porosity; reducing existing porosity would be a goal for those already at incr...

ba0004oc9 | (1) | ICCBH2015

Skeletal manifestations in pediatric WNT1 osteoporosis

Makitie Riikka , Pekkinen Minna , Laine Christine , Makitie Outi

Objectives: We recently identified a heterozygous missense mutation c.652T→G (p. C218G) in WNT1 as the cause of severe primary osteoporosis (Laine et al. New Engl J Med 2013). The mutated WNT1 reduces activation of the canonical WNT1/β-catenin-signaling, resulting in decreased osteoblastic function. The mutation was originally identified in a large Finnish family presenting with dominantly inherited, early-onset osteoporosis, with affected...

ba0004p138 | (1) | ICCBH2015

In-depth phenotyping including analyses of skin connective tissue in osteogenesis imperfecta

Balasubramanian Meena , Bishop Nick

Osteogenesis imperfecta (OI) is a heterogeneous group of inherited disorders of bone formation, resulting in low bone mass and an increased propensity to fracture. Over 90% of patients with OI have a mutation in COL1A1/COL1A2, which shows an autosomal dominant pattern of inheritance. Several other genes are associated with the autosomal recessive forms of OI. In-depth phenotyping and in particular, studies involving manifestations in the skin connective tissu...

ba0005cu1.1 | Management of osteoporosis with focus on osteoporosis in men, pregnancy and patients treated with glucocorticoids | ECTS2016

Pregnancy associated Osteoporosis: Pathophysiology and management

Zillikens Carola

Although the baby growing in its mother’s womb needs calcium for skeletal development osteoporosis and fractures very rarely occur during pregnancy. Pregnancy- and lactation-associated osteoporosis with the occurrence of fragility fractures mainly of the vertebral bodies was first described as a syndrome Nordin et al. in 1955. It is most commonly observed in the third trimester or early post-partum in women presenting with severe and prolonged back pain and somet...

ba0005oc1.2 | Clinical trials and osteoporosis treatment | ECTS2016

Acute effects of calcium supplements on blood pressure: results of a randomised cross-over trial

Bristow Sarah , Billington Emma , Gamble Greg , de Kwant Jordyn , Stewart Angela , Horne Anne , Reid Ian

Calcium supplements are associated with increased cardiovascular risk, but the mechanism by which this occurs is presently uncertain. In a secondary analysis of a trial examining the acute effects of calcium supplements, we found that blood pressure declined over 8 h in the control group, consistent with its diurnal rhythm, and that this decline was smaller in the calcium group [1]. To investigate these effects further, we carried out a randomised controlled cross-over trial o...

ba0005p177 | Cell biology: osteoclasts and bone resorption | ECTS2016

A novel regulatory factor in osteoclastogenesis DCL-1/CD302: significance of its binding to CCN2/CTGF

Aoyama Eriko , Hoshijima Mitsuhiro , Kubota Satoshi , Takigawa Masaharu

CCN2/CTGF is known as a multi-functional growth factor for various mesenchymal cells including chondrocytes, osteoblasts, vascular endothelial cells and its function is suggested to be produced by its binding to other growth factors or membrane proteins. Therefore, finding out these binding partners are critically important in understanding the molecular function of the CCN2. As a result of screening, DCL-1/CD302 was found as a new candidate of CCN2-binding molecule. DCL-1/CD3...

ba0005p206 | Cell biology: Osteocytes, mechanobiology | ECTS2016

Post traumatic bone defects treated with induced biomembrane technique in a tertiary care trauma centre – technique, results in 6 patients and a review of literature

Dawar Hitesh , Sahoo Unmesh , Raina Deepak , Rastogi Surbhit , Singh Suryakant , Wani Sayim

Introduction: Segmental bone defects arising from traumatic injuries is a complicated problem with significant long term morbidity. Amputation was the preferred treatment historically. Limb salvage by the Ilizarov technique, vascularized fibular graft, and acute limb shortening was used in the last century with variable results. The problems were long, cumbersome and patient unfriendly treatment regimens, often involving multiple major and minor surgical procedures and numerou...

ba0005p239 | Genetics and Epigenetics | ECTS2016

Search for BMD-related variants of DKK1 and SOST by resequencing in the BARCOS cohort

Martinez-Gil Nuria , Roca-Ayats Neus , Urreizti Roser , Franco-Valls Hector , Garcia-Giralt Natalia , Mellibovsky Leonardo , Nogues Xavier , Diez-Perez Adolfo , Grinberg Daniel , Balcells Susana

In a meta-analysis by Estrada et al. (2012), 56 loci were found associated with BMD, 14 of which were also associated with osteoporotic fracture. Several of these genes belong to the Wnt signaling pathway, including two inhibitors: DKK1 and SOST.To better understand the role of these genes in BMD determination and fracture susceptibility, we aimed to explore their allelic architecture by resequencing all coding exons and flanking region...